Literature DB >> 35366995

DNA vaccines join the fight against COVID-19.

Anna K Blakney1, Linda-Gail Bekker2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35366995      PMCID： PMC8970583          DOI： 10.1016/S0140-6736(22)00524-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  First COVID-19 DNA vaccine approved, others in hot pursuit.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2021-12       Impact factor: 54.908

2.  Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.

Authors:  Kayvon Modjarrad; Christine C Roberts; Kristin T Mills; Amy R Castellano; Kristopher Paolino; Kar Muthumani; Emma L Reuschel; Merlin L Robb; Trina Racine; Myoung-Don Oh; Claude Lamarre; Faraz I Zaidi; Jean Boyer; Sagar B Kudchodkar; Moonsup Jeong; Janice M Darden; Young K Park; Paul T Scott; Celine Remigio; Ajay P Parikh; Megan C Wise; Ami Patel; Elizabeth K Duperret; Kevin Y Kim; Hyeree Choi; Scott White; Mark Bagarazzi; Jeanine M May; Deborah Kane; Hyojin Lee; Gary Kobinger; Nelson L Michael; David B Weiner; Stephen J Thomas; Joel N Maslow
Journal:  Lancet Infect Dis       Date:  2019-07-24       Impact factor: 25.071

Review 3.  Engineering DNA vaccines against infectious diseases.

Authors:  Jihui Lee; Shreedevi Arun Kumar; Yong Yu Jhan; Corey J Bishop
Journal:  Acta Biomater       Date:  2018-08-31       Impact factor: 8.947

4.  Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.

Authors:  Pablo Tebas; ShuPing Yang; Jean D Boyer; Emma L Reuschel; Ami Patel; Aaron Christensen-Quick; Viviane M Andrade; Matthew P Morrow; Kimberly Kraynyak; Joseph Agnes; Mansi Purwar; Albert Sylvester; Jan Pawlicki; Elisabeth Gillespie; Igor Maricic; Faraz I Zaidi; Kevin Y Kim; Yaya Dia; Drew Frase; Patrick Pezzoli; Katherine Schultheis; Trevor R F Smith; Stephanie J Ramos; Trevor McMullan; Karen Buttigieg; Miles W Carroll; John Ervin; Malissa C Diehl; Elliott Blackwood; Mammen P Mammen; Jessica Lee; Michael J Dallas; Ami Shah Brown; Jacqueline E Shea; J Joseph Kim; David B Weiner; Kate E Broderick; Laurent M Humeau
Journal:  EClinicalMedicine       Date:  2020-12-24

5.  Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.

Authors:  Martin R Gaudinski; Katherine V Houser; Kaitlyn M Morabito; Zonghui Hu; Galina Yamshchikov; Ro Shauna Rothwell; Nina Berkowitz; Floreliz Mendoza; Jamie G Saunders; Laura Novik; Cynthia S Hendel; LaSonji A Holman; Ingelise J Gordon; Josephine H Cox; Srilatha Edupuganti; Monica A McArthur; Nadine G Rouphael; Kirsten E Lyke; Ginny E Cummings; Sandra Sitar; Robert T Bailer; Bryant M Foreman; Katherine Burgomaster; Rebecca S Pelc; David N Gordon; Christina R DeMaso; Kimberly A Dowd; Carolyn Laurencot; Richard M Schwartz; John R Mascola; Barney S Graham; Theodore C Pierson; Julie E Ledgerwood; Grace L Chen
Journal:  Lancet       Date:  2017-12-05       Impact factor: 202.731
  5 in total
  1 in total

Review 1.  Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines.

Authors:  Mohammad Reza Sepand; Banafsheh Bigdelou; Jim Q Ho; Mohammad Sharaf; Alexis J Lannigan; Ian M Sullivan; Alecsander P da Silva; Leland O Barrett; Scott McGoldrick; Yuvraj Lnu; Shannon E Lynch; Jared M Boisclair; Dakarai D Barnard-Pratt; Steven Zanganeh
Journal:  Antibodies (Basel)       Date:  2022-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.